Savant Capital LLC Makes New Investment in Varex Imaging $VREX

Savant Capital LLC bought a new position in shares of Varex Imaging (NASDAQ:VREX) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 17,820 shares of the company’s stock, valued at approximately $154,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of VREX. Wealth Enhancement Advisory Services LLC increased its stake in Varex Imaging by 25.5% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 13,104 shares of the company’s stock worth $115,000 after buying an additional 2,659 shares in the last quarter. Fox Run Management L.L.C. boosted its stake in shares of Varex Imaging by 11.6% in the first quarter. Fox Run Management L.L.C. now owns 32,011 shares of the company’s stock worth $371,000 after acquiring an additional 3,320 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Varex Imaging by 58.0% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,279 shares of the company’s stock worth $131,000 after acquiring an additional 4,139 shares during the last quarter. State of Wyoming increased its position in shares of Varex Imaging by 42.0% during the first quarter. State of Wyoming now owns 16,626 shares of the company’s stock worth $193,000 after purchasing an additional 4,918 shares in the last quarter. Finally, Quarry LP acquired a new position in Varex Imaging in the 1st quarter valued at $63,000.

Wall Street Analysts Forecast Growth

VREX has been the topic of several recent research reports. Wall Street Zen cut shares of Varex Imaging from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. Oppenheimer decreased their price target on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday. B. Riley reaffirmed a “buy” rating and set a $16.00 price objective on shares of Varex Imaging in a research note on Wednesday. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Varex Imaging in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $17.00.

Varex Imaging Stock Performance

Varex Imaging stock opened at $10.29 on Friday. The firm has a 50 day simple moving average of $11.79 and a 200-day simple moving average of $9.84. The stock has a market cap of $429.09 million, a price-to-earnings ratio of -6.05 and a beta of 0.98. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.43 and a quick ratio of 1.82. Varex Imaging has a 1-year low of $6.76 and a 1-year high of $16.93.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings results on Tuesday, November 18th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.18 by $0.19. The firm had revenue of $228.90 million for the quarter, compared to analyst estimates of $219.26 million. Varex Imaging had a negative net margin of 8.32% and a positive return on equity of 7.19%. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. On average, analysts expect that Varex Imaging will post 0.53 EPS for the current year.

Varex Imaging Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.